Patent Owner's Self-Contradictory Expert Testimony Leads To JMOL Of No Infringement
Client Alert | 2 min read | 10.08.08
In The Johns Hopkins University et al. v. Datascope Corp. (2007-1530; October 2, 2008), Johns Hopkins sued Datascope for infringing three U.S. patents directed to methods for mechanically fragmenting blood clots. At trial, a jury found, inter alia, that Datascope infringed all of the asserted claims of the three patents. In response, Datascope filed a motion for judgment as a matter of law (JMOL) or for a new trial, which was denied by the district court. Datascope then appealed. A divided panel of the Federal Circuit holds that the jury's conclusion was not supported by substantial evidence and that Datascope's motion for JMOL should have been granted.
The methods of the Johns Hopkins patents involve a fragmentation cage or basket at the distal end of a catheter. In contrast, Datascope's ProLumen device uses an S-shaped wire to mechanically fragment blood clots. At issue was whether the Datascope device included a "fragmentation member" that "expands to conform to the shape and diameter of the inner lumen." According to the district court's jury instructions, the fragmentation member "expands and adjusts to remain in contact with the inner lumen in three dimensions along its length and width." The panel majority states that the only evidence as to whether Datascope's device literally met the claim limitations was provided by expert testimony. In particular, the Johns Hopkins expert opined that the S-wire in the ProLumen device expands and adjusts to remain in contact with the inner lumen in three dimensions upon deployment, but conceded that, prior to rotation, the S-wire only contacts the inner lumen at two points. The panel majority concludes that the testimony of the Johns Hopkins expert is contradictory and incredible, because it is impossible for the two contact points of the S-wire to meet the three dimensions aspect of the "expands to conform" limitation, and thus that testimony is incapable of providing substantial evidence to support the jury verdict. Accordingly, the panel majority concludes that no reasonable jury could have found that Datascope's device infringed based on the expert's opinion.
In a separate opinion, Judge Newman dissented, arguing that panel majority was inappropriately retrying the facts, which had been decided by the jury and sustained by the district court. Judge Newman argues that in reviewing a jury verdict, the appellate court must draw all reasonable inferences in favor of the verdict, without making credibility determinations and without reweighing the evidence.
Contacts
Insights
Client Alert | 5 min read | 08.21.26
FTC Proposes Enforcement Policy Statement on Personalized Pricing: What Businesses Need to Know
On August 19, 2026, the Federal Trade Commission (FTC) announced a proposed Enforcement Policy Statement on personalized pricing — the practice of companies using consumers’ personal data to set individualized prices, discounts, coupons, or other incentives. The proposed statement, which is open for public comment for 30 days following publication in the Federal Register, marks a major step up in the FTC’s focus on data-driven pricing strategies and puts businesses across industries on notice that undisclosed or inadequately disclosed personalized pricing will not be tolerated. Importantly, while the proposed statement is not a binding legal requirement and does not create new legal obligations, it serves as an enforcement warning that the FTC is prepared to use its existing enforcement authority under Section 5 of the FTC Act (Section 5) and is also a potential harbinger of rulemaking. Businesses that engage in — or are considering — personalized pricing should carefully assess their disclosure practices and data collection procedures against the standards articulated in this statement.
Client Alert | 7 min read | 08.19.26
CMS’s Final Rule Bans Federal Medicaid Funding for Youth Gender-Affirming Care
Client Alert | 2 min read | 08.19.26

